Skip to main content
Irene De Biase

Irene De Biase, MD, PhD

Languages spoken: Italian, English

Academic Information

Departments Primary - Pathology

Board Certification

  • American Board of Medical Genetics (Clinical Biochemical Genetics)

Education History

Professional Medical Federico II University
MD
Doctoral Training Federico II University
PhD
Postdoctoral Fellowship University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology
Postdoctoral Fellow
Fellowship Greenwood Genetic Center
Fellow

Selected Publications

Journal Article

  1. De Biase I, Yuzyuk T, Cui W, Zuromski LM, Moser AB, Braverman N (2023). Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders. Clinica chimica acta; international journal of clinical chemistry, 542, 117295.
  2. Yuzyuk T, McDonald CM, Zuromski LM, De Biase I, Johnson L, Williams N, Meihls S, Asfour (2023). Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy. Journal of cystic fibrosis,
  3. Prinzi J, Pasquali M, Hobert JA, Palmquist R, Wong KN, Francis S, De Biase (2023). Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective. International journal of neonatal screening, 9(4),
  4. Duque Lasio ML, Zaitsev M, Hobert JA, De Biase I, Pasquali M, Yuzyuk (2025). C4OH-carnitine: an important marker of ketosis in patients with and without inborn errors of metabolism. Molecular genetics and metabolism, 145(4), 109160.
  5. Yuzyuk T, McDonald CM, Balogun K, Zuromski LM, De Biase I, Williams N, Meihls S, Asfour F (2025). Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators. Journal of cystic fibrosis, S1569-1993(25), 02495-6.

Case Report

  1. De Biase I, de Dios K, Brose SA, Hobert J (2024). Autism Spectrum Disorder and Mild Developmental Delay in a Patient with a Rare Inborn Error of Metabolism. Clinical chemistry, 70(6), 882-884.
  2. Coody TK, De Biase I, Porter JM, Pasquali M, Shayota B (2025). Clinical and biochemical characterization of a patient with prolidase deficiency, a rare disorder of collagen metabolism. Molecular genetics and metabolism reports, 45, 101258.

Abstract

  1. Nelson HA, De Biase I, Balogun K, McDonald CM, Meihls S, Asfour F, Yuzyuk (2023). CFTR Modulator Therapy Increases Plasma Concentrations of Vitamin A in Patients with Cystic Fibrosis. 69(1, Supplement), A-340.